Menu Menu

ANAB    Anaptysbio Inc    1370053    
Income Statement
Revenue 30,017,000
Net Income -32,851,000
Profit Margin -109.44%

Balance Sheet
Current Assets 448,681,000
Assets 493,418,000
Current Liabilities 43,880,000
Liabilities 409,051,000
Equity 84,367,000
Shares Out 30,200,000

Cash Flow Statement
Operating Cash Flow -68,665,000
Investing Cash Flow 124,794,000

Market Analysis
Market Cap 1,148,309,672
Price 15.85
BVPS 2.79
PB 5.56
EPS -6.34
PS 9.56
FCF 56,129,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
3/11 1.17
Apr May Jun
5/09 -1.64
Jul Aug Sep
8/05 -1.71
Oct Nov Dec
10/31

Find a discrepancy? The most accurate way to find company fundamental data is to view ANAB documents filed with the SEC.


ANAB Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: